AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.
Tag: Drugs (Pharmaceuticals)
-
Why Experts Are Urging Swifter Treatment for Children With Obesity
Growing research has shown that intensive interventions are needed, scientists say. Here is why their advice is changing.
-
New Lawsuit Challenges State Bans on Abortion Pills
The case, brought by GenBioPro, a company that makes one of two abortion drugs, argues that it is unconstitutional for a state to bar access to a medication approved by the federal government.
-
A Dilemma for Governments: How to Pay for Million-Dollar Therapies
A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.
-
I Lost Weight on Ozempic. Here’s What the Debate Gets Wrong.
Why one doctor believes obesity should be treated like any disease — with medication.